It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes
Poster session I - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.06 - CARDIOEMBOLISM & HEART-BRAIN INTERACTIONS P354 - ESOC25-107 ATRIAL CARDIOMYOPATHY AND MRI-DETECTED COVERT BRAIN INFARCTION IN A MIDDLE-AGED POPULATION-BASED COHORT: THE AKERSHUS CARDIAC EXAMINATION 1950 STUDY Hkon Ihle-Hansen 1 , Magnar Gangs Solberg 2 , Marte Meyer Walle-Hansen 2 , Thea Vigen 3 , Guri Hagberg 4 , Hege Ihle-Hansen 5 , Bente Thommessen 3 , Ole Morten Ronning, Magnus Nakrem Lyngbakken 6 , Peter Rnningen 2 , On Behalf of THE Akershus Cardiac Examination 1950 Study Team 7 1 Department of Medical Research, Brum Hospital, Vestre Viken Hospital Trust, Department of Medicine, Brum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway, 2 Department of Medical Research, Brum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway, 3 Department of Neurology, Division of Medicine, Akershus University Hospital, Lrenskog, Lrenskog, Norway, 4 Department of Medical Research, Brum Hospital, Vestre Viken Hospital Trust, Stroke Unit, Department of Neurology, Oslo University Hospital, Ullevaal, Oslo, Gjettum, Norway, 5 Department of Medical Research, Brum Hospital, Vestre Viken Hospital Trust, Department of acute medicine, Oslo University Hospital, Ullevaal, Oslo, Gjettum, Norway, 6 Division of Medicine, Akershus University Hospital, Lrenskog, Lrenskog, Norway, 7 Brum Hospital, Vestre Viken Hospital Trust, Akershus University Hospital, Gjettum and Lrenskog, Norway Background and Aims: Atrial fibrillation (AF) is linked to clinical stroke and covert brain infarction (CBI)
In rat with the treatment of 10 g/Kg/day BPC 157, the concentration of BPC 157 was estimated to be less than 1 g/ml in the blood which was too low to cause hypotension or hemodynamic change as demonstrated by the lack of vasodilation in the present study 6
Standard dosing: 250-500mcg once or twice daily represents the most common protocol
Pharmaceutical-grade peptides from reputable suppliers undergo testing for purity, sterility, and accurate concentration
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans
